2m 2m 2m 2m 2m 2m 2m
PASITHEA THERAP (KTTA)
NASDAQ
$0.56+$0.02 (+3.92%)
Price as of Jun 23, 2026 7:51 PM EDT- $18.0MMarket Cap
- -25.08%1-Year Change
- BiotechnologyIndustry
PASITHEA THERAP (KTTA)
$0.56+$0.02 (+3.92%)
KTTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.54 | ||
Change | +$0.04 (+7.78%) | ||
Open | $0.51 | ||
High | $0.59 | ||
Low | $0.50 | ||
Previous Close | $0.50 | ||
Volume | 546,336 | ||
30-Day Average Volume | 508,350 | ||
1-Week Change | -3.77% | ||
1-Month Change | -22.99% | ||
1-Year Change | -25.08% | ||
3-Year Change | -93.76% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 33.4M | ||
Total Assets | $56.4M | ||
Market Cap | $18.0M | ||
Enterprise Value | -$32.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.8M | ||
Free Cash Flow | -$4.8M | ||
EBIT | -$2.8M | ||
EBITDA | -$2.7M | ||
Net Working Capital | $51.2M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | 12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 01/02/2024 | ||
Earnings & Revenue